Home dialysis device gets safety check in ongoing study
NCT ID NCT04198012
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study allowed 25 people with end-stage kidney disease to keep using the HemoCare hemodialysis system at home while the device was being reviewed for market approval. The main goal was to track safety events like side effects or device problems. Participants needed a trained care partner to help with treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HemoCare™ Hemodialysis System (a device for home hemodialysis)
- What this could lead to
- If successful, this could help make home hemodialysis more accessible for people with kidney failure, offering more flexibility and convenience.
- What could go wrong
- This is a small, completed study focused on continued access and safety monitoring, not a test of new benefits. The device still requires a trained care partner and may not suit everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DCI North Brunswick
North Brunswick, New Jersey, 08902, United States
-
Dialysis Clinic, Inc.
Knoxville, Tennessee, 37920, United States
-
Dialysis Clinic, Inc.
Nashville, Tennessee, 37203, United States
-
The Rogosin Institute
New York, New York, 11021, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39213, United States
-
Wellbound North Austin
Austin, Texas, 78758, United States
-
Wellbound South Austin
Austin, Texas, 78744, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug work safely in patients with kidney failure?
- What does life feel like for children with a rare birth defect? a new study asks
- AI therapy coach aims to ease distress in seriously ill seniors
- A simple stretch during dialysis might soothe restless legs
- A regenerative graft could rethink dialysis access
- Pumpkin seed oil may fight inflammation in kidney patients — a trial puts it to the test